Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Grosbois

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
La Revue De Medecine Interne|January 1, 1990
[IgM myeloma: 6 cases and a review of the literature]A De Gramont, B Grosbois, J L Michaux, et al.
Blood|July 27, 2000
patients with the description of a new scoring system and its validation on 253 other patientsP Morel, M Monconduit, D Jacomy, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Thalidomide in patients with advanced multiple myelomaI Yakoub-Agha, P Moreau, S Leyvraz, et al.
British Journal of Haematology|February 1, 1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)M Monconduit, J F Menard, J L Michaux, et al.
Journal of Inherited Metabolic Disease|June 10, 2010
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)P Chérin, C Rose, C de Roux-Serratrice, et al.
Leukemia & Lymphoma|November 1, 1996
Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcomeJ E Goasguen, T Lamy, C Bergeron, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 5, 2010
Vertebral fractures in Gaucher disease type I: data from the French "Observatoire" on Gaucher disease (FROG)R-M Javier, E Hachulla, C Rose, et al.
British Journal of Haematology|December 1, 1996
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)C Mathiot, J Y Mary, E Tartour, et al.
Leukemia|January 17, 2003
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patientsF Maloisel, L Benboubker, M Gardembas, et al.
British Journal of Haematology|November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)P Mineur, J F Ménard, X Le Loët, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
La Revue De Medecine Interne|January 1, 1990
[IgM myeloma: 6 cases and a review of the literature]A De Gramont, B Grosbois, J L Michaux, et al.
Blood|July 27, 2000
patients with the description of a new scoring system and its validation on 253 other patientsP Morel, M Monconduit, D Jacomy, et al.
The Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Thalidomide in patients with advanced multiple myelomaI Yakoub-Agha, P Moreau, S Leyvraz, et al.
British Journal of Haematology|February 1, 1992
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM)M Monconduit, J F Menard, J L Michaux, et al.
Journal of Inherited Metabolic Disease|June 10, 2010
The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)P Chérin, C Rose, C de Roux-Serratrice, et al.
Leukemia & Lymphoma|November 1, 1996
Multifactorial drug-resistance phenomenon in acute leukemias: impact of P170-MDR1, LRP56 protein, glutathione-transferases and metallothionein systems on clinical outcomeJ E Goasguen, T Lamy, C Bergeron, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 5, 2010
Vertebral fractures in Gaucher disease type I: data from the French "Observatoire" on Gaucher disease (FROG)R-M Javier, E Hachulla, C Rose, et al.
British Journal of Haematology|December 1, 1996
Soluble CD16 (sCD16), a marker of malignancy in individuals with monoclonal gammopathy of undetermined significance (MGUS)C Mathiot, J Y Mary, E Tartour, et al.
Leukemia|January 17, 2003
Long-term outcome with pentostatin treatment in hairy cell leukemia patients. A French retrospective study of 238 patientsF Maloisel, L Benboubker, M Gardembas, et al.
British Journal of Haematology|November 25, 1998
VAD or VMBCP in multiple myeloma refractory to or relapsing after cyclophosphamide-prednisone therapy (protocol MY 85)P Mineur, J F Ménard, X Le Loët, et al.
Pageof 8